Poland· PL-100474160
Ticagrelor Farmak
A ticagrelor product containing ticagrelorum, registered in Poland by Farmak International Sp. z o.o.. The same ATC class is registered in 18 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Ticagrelor is registered in 18 of 19 countries.
Countries holding a registration under ATC B01AC24 (ticagrelor), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 10 of them publish a price we can compare per daily dose
Ticagrelor · ATC B01AC24
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ticagrelor costs, country by country.
Normalised to the WHO defined daily dose (0.18 g), the median price runs from $0.68 in United States to $1.97 in Spain — a ×2.9 gap.
- 5 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Ticagrelor · price per daily dose (0.18 g)
USD · FX 28 Sept 2026
- ES Spain$1.97
- CH Switzerland$1.80
- IT Italy$0.94
- FR France$0.77
- US United States$0.68 (acquisition cost)
The record
At a glance
URPL (Poland)- Active substance
- Ticagrelorum
- Manufacturer
- Farmak International Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- B01AC24
- ATC class
- Ticagrelor
- Defined daily dose
- 0.18 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991532758
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
529 interactions on record for ticagrelor.
Graded by severity as the source publishes them — 76 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ticagrelor · interactions on record
529 records
- 76 severe
- 354 moderate
- 60 minor
Most severe, free to view
- LonafarnibA16AX20severe
- DalteparinB01AB04severe
- EnoxaparinB01AB05severe
- DanaparoidB01AB09severe
39 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ticagrelor in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaATIRABOTAD Pharma GmbH, Cuxhaven
- SpainBRILIQUE 90 MG COMPRIMIDOS RECUBIERTOS CON PELICULAAstrazeneca Ab
- SwitzerlandBrilique
- SwedenAuretica 90 mg Filmdragerad tablettAurora Licensing S.r.l.
- NetherlandsBrilique 90 mg, filmomhulde tablettenAstraZeneca AB (Gärtunavägen)
- United StatesTicagrelorLifestar Pharma LLC
- ItalyAURETICAAURORA LICENSING S.R.L.
- FinlandBriliqueAstraZeneca AB
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Ticagrelor, Ticagrelor Accord
- Belgium · Ticagrelor Ab, Ticagrelor Eg
- Bulgaria · ?????????? Accord, Tilobrastil
- Cyprus · Brirem, Lacrat
- Czechia · Atirabo, Atixarso
- Germany · Ticabril, Ticagrelor
- Denmark · Lacrat, Ticagrelor Accord
- Estonia · Agtileq, Atirabo
- Spain · Lacrat, Ticagrelor Abdi
- Finland · Ticagrelor Accord, Ticagrelor Avansor
- France · Ticagrelor Accord, Ticagrelor Arrow
- United Kingdom (Northern Ireland) · Bellaflow, Clariflow
- Greece · Agilinta, Atixarso
- Croatia · Atixarso, Greccas
- Hungary · Atirabo, Atixarso
- Ireland · Ticagrelor Accord, Ticagrelor Bluefish
- Iceland · Brilique, Ticagrelor Krka
- Italy · Auretica, Ticagrelor
- Liechtenstein · Brilique
- Lithuania · Atirabo, Atixarso
- Luxembourg · Ticagelor Eg (Eurogenerics) Nv, Ticagrelor Eg
- Latvia · Atirabo, Atixarso
- Malta · Brirem, Croalcril
- Netherlands · Ticagrelor Abdi, Ticagrelor Accord
- Norway · Brilique, Ticagrelor Accord
- Portugal · Brirem, Lacrat Mg
- Romania · Atixarso, Croalcril
- Sweden · Auretica, Ecugra
- Slovenia · Atixarso, Lacrat
- Slovakia · Atirabo, Atixarso
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d7e6188d-1b3f-481b-9ec5-6f44d8e290c8 GET /v1/drugs/d7e6188d-1b3f-481b-9ec5-6f44d8e290c8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "90 mg",
"packaging": "05909991532758 ¦ Rp ¦ 153400\n56 tabl.",
"substance": "Ticagrelorum 90 mg",
"common_name": "Ticagrelorum",
"pl_product_id": "100474160",
"pozwolenie_nr": "28344",
"auth_procedure": "DCP",
"authorisation_validity": "2029-04-08"
}See everything about ticagrelor.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.